PMV Pharmaceuticals
PMVP • NASDAQ
PMV Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David H. Mack, with a market cap of $70.9M.
Market Cap$70.9M
Employees63.0
CEODavid H. Mack
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
PMV
PMV Pharmaceuticals FAQ
Common questions about PMV Pharmaceuticals
PMV Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 8, 2026.
PMV Pharmaceuticals has approximately 63 employees.